VAUGHAN, Ontario (AP) — VAUGHAN, Ontario (AP) — Bausch + Lomb Corporation (BLCO) on Wednesday reported third-quarter net income of $4 million, after reporting a loss in the same period a year earlier.

Bausch + Lomb (NYSE:BLCO – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens ...

All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of the call. Conference Call Details About Bausch + Lomb Bausch + Lomb is ...

Banks and private credit firms are competing to provide at least $5 billion of debt financing to help fund a potential buyout ...

Monday was an eventful day for Bausch + Lomb (NYSE: BLCO). The eye care specialist's major piece of internal news was that it earned its latest Food and Drug Administration (FDA) approval.

Evercore ISI upgraded shares of Bausch + Lomb (NYSE:BLCO – Free Report) from an in-line rating to an outperform rating in a ...

Bausch + Lomb shares surged Monday following reports Blackstone and TPG are considering teaming up to buy the eyecare company ...

RBC Capital analyst Douglas Miehm raised the firm’s price target on Bausch Health (BHC) to $10 from $8.50 and keeps a Sector Perform ...

All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of the call.

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its third-quarter 2024 financial results on ...